|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
|
3 Months Ended |
|
Mar. 31, 2015
|
Mar. 31, 2014
|
| CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
| Net income (loss) |
$ 4,386 |
$ (10,474) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
| Depreciation and amortization |
5,515 |
8,712 |
| Amortization of inventory step-up in fair value |
0 |
2,896 |
| Share-based compensation |
4,063 |
3,145 |
| Deferred tax, net |
(977) |
(284) |
| (Gain) loss on sales of securities |
(59) |
15 |
| Other non-cash transactions |
291 |
134 |
| Changes in operating assets and liabilities: |
|
|
| Accounts receivable, net |
(2,035) |
130 |
| Inventories |
145 |
(2,456) |
| Prepaid expenses and other assets |
(916) |
2,191 |
| Accounts payable and accrued liabilities |
(9,533) |
3,205 |
| Deferred revenue |
(309) |
(2,527) |
| Other long-term liabilities |
771 |
(82) |
| Net cash provided by operating activities |
1,342 |
4,605 |
| CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
| Proceeds on sale of fixed assets |
0 |
106 |
| Capital expenditures |
(2,297) |
(1,111) |
| Purchase of technology rights |
(41) |
0 |
| Net cash used in investing activities |
(2,338) |
(1,005) |
| CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
| Issuance of common stock, net of issuance costs |
26,658 |
184 |
| Repayments of long-term debt |
(1,000) |
(3,250) |
| Net cash provided by (used in) financing activities |
25,658 |
(3,066) |
| Effect of exchange rate changes on cash and cash equivalents |
(576) |
44 |
| Net increase in cash and cash equivalents |
24,086 |
578 |
| Cash and cash equivalents at beginning of period |
79,923 |
57,128 |
| Cash and cash equivalents at end of period |
$ 104,009 |
$ 57,706 |